K. Tekin Et Al. , "Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study," SEMINARS IN OPHTHALMOLOGY , vol.33, no.2, pp.265-270, 2018
Tekin, K. Et Al. 2018. Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study. SEMINARS IN OPHTHALMOLOGY , vol.33, no.2 , 265-270.
Tekin, K., Sekeroglu, M. A., ÇANKAYA, A. B., Teke, M. Y., Doguizi, S., & Yilmazbas, P., (2018). Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study. SEMINARS IN OPHTHALMOLOGY , vol.33, no.2, 265-270.
Tekin, Kemal Et Al. "Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study," SEMINARS IN OPHTHALMOLOGY , vol.33, no.2, 265-270, 2018
Tekin, Kemal Et Al. "Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study." SEMINARS IN OPHTHALMOLOGY , vol.33, no.2, pp.265-270, 2018
Tekin, K. Et Al. (2018) . "Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study." SEMINARS IN OPHTHALMOLOGY , vol.33, no.2, pp.265-270.
@article{article, author={Kemal Tekin Et Al. }, title={Intravitreal Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study}, journal={SEMINARS IN OPHTHALMOLOGY}, year=2018, pages={265-270} }